Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction

Area of Science:

• Proteomics
• Molecular Biology
• Diabetic Complications

Background:

• Streptozotocin-induced diabetes mellitus (STZ-DM) in rats is a model for studying diabetic complications.
• Bladder smooth muscle dysfunction is a known complication of diabetes.

Purpose of the Study:

• To investigate the proteomic changes in rat bladder smooth muscle at early and late stages of STZ-induced diabetes.
• To identify proteins involved in the pathogenesis of diabetic bladder complications.

Main Methods:

• Differential gel electrophoresis (DIGE) coupled with mass spectrometry (MS) was used to analyze protein expression.
• Rat bladder smooth muscle tissues from STZ-DM and control groups were analyzed at 1 week and 2 months post-STZ treatment.
• Network analysis was performed using MetaCore to interpret protein interactions.

Main Results:

• A total of 56 unique proteins were identified with significant expression changes.
• Early changes (1 week) included 10 differentially expressed proteins.
• Later changes (2 months) revealed down-regulation of cell adhesion and extracellular matrix proteins, and up-regulation of proteins involved in muscle contraction, glycolysis, inflammation, and cell proliferation.

Conclusions:

• STZ-induced diabetes leads to significant proteomic alterations in bladder smooth muscle.
• Down-regulation of structural and extracellular matrix proteins may impair muscle function.
• Upregulation of inflammatory and proliferative proteins suggests their role in diabetic bladder dysfunction.